<VariationArchive VariationID="3243542" VariationName="NC_000016.9:g.(?_14720953)_(14721203_?)del" VariationType="Deletion" Accession="VCV003243542" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3406009" VariationID="3243542">
      <GeneList>
        <Gene Symbol="PARN" FullName="poly(A)-specific ribonuclease" GeneID="5073" HGNC_ID="HGNC:8609" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="14435701" stop="14630260" display_start="14435701" display_stop="14630260" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NT_187607.1" start="8558" stop="203161" display_start="8558" display_stop="203161" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="14529556" stop="14724127" display_start="14529556" display_stop="14724127" Strand="-" />
          </Location>
          <OMIM>604212</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000016.9:g.(?_14720953)_(14721203_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" innerStart="14720953" innerStop="14721203" display_start="14720953" display_stop="14721203" variantLength="251" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.(?_14720953)_(14721203_?)del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.(?_14720953)_(14721203_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000016.9:g.(?_14720953)_(14721203_?)del AND multiple conditions" Accession="RCV004582770" Version="1">
        <ClassifiedConditionList TraitSetID="36521">
          <ClassifiedCondition DB="MedGen" ID="C4225356">Dyskeratosis congenita, autosomal recessive 6</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4225347">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31448843</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="36521" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33357" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4</ElementValue>
                <XRef ID="MONDO:0014612" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 4</ElementValue>
                <XRef Type="MIM" ID="616371" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604212.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604212.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604212.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604212.0006" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PFBMFT4</ElementValue>
                <XRef Type="MIM" ID="616371" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16097" />
                <XRef ID="16097" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301408</ID>
                <ID Source="BookShelf">NBK1230</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="2032" DB="Orphanet" />
              <XRef ID="C4225347" DB="MedGen" />
              <XRef ID="MONDO:0014612" DB="MONDO" />
              <XRef Type="MIM" ID="616371" DB="OMIM" />
            </Trait>
            <Trait ID="33330" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal recessive 6</ElementValue>
                <XRef ID="MONDO:0014600" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DKCB6</ElementValue>
                <XRef Type="MIM" ID="616353" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16095" />
                <XRef ID="16095" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="C4225356" DB="MedGen" />
              <XRef ID="MONDO:0014600" DB="MONDO" />
              <XRef Type="MIM" ID="616353" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9834035" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000016.9:g.(?_14720953)_(14721203_?)del|MedGen:C4225356;C4225347" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005062360" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31448843</ID>
          </Citation>
          <Comment>This variant disrupts a region of the PARN protein in which other variant(s) (p.Tyr91Cys) have been determined to be pathogenic (PMID: 31448843; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with PARN-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 4-5 of the PARN gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.(?_14720953)_(14721203_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225356" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225347" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9834035" TraitType="Disease" MappingType="XRef" MappingValue="C4225347" MappingRef="MedGen">
        <MedGen CUI="C4225347" Name="Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9834035" TraitType="Disease" MappingType="XRef" MappingValue="C4225356" MappingRef="MedGen">
        <MedGen CUI="C4225356" Name="Dyskeratosis congenita, autosomal recessive 6" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

